Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 246,620 |
|
|||||
| News | - | ||||||
| Day High | 1.61 | Low High |
|||||
| Day Low | 1.56 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| aTyr Pharma Inc | LIFE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.63% | 1.61 | 16:47:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.58 | 1.56 | 1.61 | 1.57 | 1.60 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,357 | 246,620 | US$ 1.58 | US$ 390,889 | - | 1.0801 - 2.6999 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:47:13 | formt | 100 | US$ 1.61 | USD |
aTyr Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 107.05M | 67.75M | - | 353k | -50.39M | -0.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
aTyr Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LIFE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.68 | 1.695 | 1.5402 | 1.60 | 371,327 | -0.07 | -4.17% |
| 1 Month | 1.89 | 1.94 | 1.5402 | 1.70 | 357,403 | -0.28 | -14.81% |
| 3 Months | 1.72 | 2.15 | 1.5402 | 1.84 | 580,728 | -0.11 | -6.40% |
| 6 Months | 1.18 | 2.15 | 1.0801 | 1.65 | 462,211 | 0.43 | 36.44% |
| 1 Year | 1.96 | 2.6999 | 1.0801 | 1.85 | 410,040 | -0.35 | -17.86% |
| 3 Years | 4.03 | 13.10 | 1.0801 | 7.03 | 709,539 | -2.42 | -60.05% |
| 5 Years | 9.31 | 13.10 | 1.0801 | 6.49 | 590,077 | -7.70 | -82.71% |
aTyr Pharma Description
| aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. |
